(Q85406998)
Statements
Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 as monotherapy in patients with hypercholesterolaemia (MENDEL): a randomised, double-blind, placebo-controlled, phase 2 study (English)
Michael J Koren
Rob Scott
Jae B Kim
Beat Knusel
Thomas Liu
Lei Lei
Michael Bolognese
Scott M Wasserman
6 November 2012